MolNFT v1 · #126817 · protein
Crystal structure of yeast CDT1 (N terminal and middle domain), form 2.
5MEA · Cell division cycle protein CDT1: “Crystal structure of yeast CDT1 (N terminal and middle domain), form 2.”. X-ray diffraction, 1 ligand (SO4), 3 pockets (best druggability 0.55). MolNFT v1 #126817 on GenesisL1: 3D structure…
- PDB
- 5MEA
- Type
- protein
- Length
- 386 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Cell division cycle protein CDT1
- UniProt
- P47112
- Ligands
- SO4
- Pockets
- 3 · best druggability 0.55
Structure
x-ray diffraction · 1 distinct chain · 40% helix, 19% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Cell division cycle protein CDT1 | protein | 386 | 40% helix, 19% strand | P47112 |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 175 | 0.55 | 0.80 | 39 | GOL |
| 2 | 66 | 0.38 | 0.78 | 17 | empty |
| 3 | 57 | 0.38 | 0.79 | 13 | empty |
Compared structures
- 5MEA · Crystal structure of yeast Cdt1 (N terminal and middle domain), form 2. · the same entry in another collection · chain A against A, TM-score 1.00
- P47112 · AlphaFold monomer V2.0 prediction for cell division cycle protein CDT1 (P47112) · a predicted model of the same protein · chain A against A, TM-score 0.98
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P47112
- Elsewhere: RCSB PDB 5MEA · PDBe 5MEA · UniProt P47112
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.